Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis
- PMID: 31913488
- PMCID: PMC6991241
- DOI: 10.1001/jamanetworkopen.2019.17597
Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis
Abstract
Importance: An understanding of the incidence and outcomes of Clostridium difficile infection (CDI) in the United States can inform investments in prevention and treatment interventions.
Objective: To quantify the incidence of CDI and its associated hospital length of stay (LOS) in the United States using a systematic literature review and meta-analysis.
Data sources: MEDLINE via Ovid, Cochrane Library Databases via Wiley, Cumulative Index of Nursing and Allied Health Complete via EBSCO Information Services, Scopus, and Web of Science were searched for studies published in the United States between 2000 and 2019 that evaluated CDI and its associated LOS.
Study selection: Incidence data were collected only from multicenter studies that had at least 5 sites. The LOS studies were included only if they assessed postinfection LOS or used methods accounting for time to infection using a multistate model or compared propensity score-matched patients with CDI with control patients without CDI. Long-term-care facility studies were excluded. Of the 119 full-text articles, 86 studies (72.3%) met the selection criteria.
Data extraction and synthesis: Two independent reviewers performed the data abstraction and quality assessment. Incidence data were pooled only when the denominators used the same units (eg, patient-days). These data were pooled by summing the number of hospital-onset CDI incident cases and the denominators across studies. Random-effects models were used to obtain pooled mean differences. Heterogeneity was assessed using the I2 value. Data analysis was performed in February 2019.
Main outcomes and measures: Incidence of CDI and CDI-associated hospital LOS in the United States.
Results: When the 13 studies that evaluated incidence data in patient-days due to hospital-onset CDI were pooled, the CDI incidence rate was 8.3 cases per 10 000 patient-days. Among propensity score-matched studies (16 of 20 studies), the CDI-associated mean difference in LOS (in days) between patients with and without CDI varied from 3.0 days (95% CI, 1.44-4.63 days) to 21.6 days (95% CI, 19.29-23.90 days).
Conclusions and relevance: Pooled estimates from currently available literature suggest that CDI is associated with a large burden on the health care system. However, these estimates should be interpreted with caution because higher-quality studies should be completed to guide future evaluations of CDI prevention and treatment interventions.
Conflict of interest statement
Figures
Comment in
-
Incidence and Outcome of Clostridium difficile Infection-Beware of Strain Type and Diagnostic Tests.JAMA Netw Open. 2020 Jan 3;3(1):e1918599. doi: 10.1001/jamanetworkopen.2019.18599. JAMA Netw Open. 2020. PMID: 31913485 No abstract available.
Similar articles
-
Hospital Clostridium difficile Infection Rates and Prediction of Length of Stay in Patients Without C. difficile Infection.Infect Control Hosp Epidemiol. 2016 Apr;37(4):404-10. doi: 10.1017/ice.2015.340. Epub 2016 Feb 9. Infect Control Hosp Epidemiol. 2016. PMID: 26858126 Free PMC article.
-
Attributable Cost of Clostridium difficile Infection in Pediatric Patients.Infect Control Hosp Epidemiol. 2017 Dec;38(12):1472-1477. doi: 10.1017/ice.2017.240. Epub 2017 Nov 27. Infect Control Hosp Epidemiol. 2017. PMID: 29173236
-
Epidemiologic Trends in Clostridioides difficile Infections in a Regional Community Hospital Network.JAMA Netw Open. 2019 Oct 2;2(10):e1914149. doi: 10.1001/jamanetworkopen.2019.14149. JAMA Netw Open. 2019. PMID: 31664443 Free PMC article.
-
Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.BMC Infect Dis. 2021 May 19;21(1):456. doi: 10.1186/s12879-021-06147-y. BMC Infect Dis. 2021. PMID: 34016040 Free PMC article.
-
Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.J Hosp Infect. 2014 Sep;88(1):12-21. doi: 10.1016/j.jhin.2014.04.011. Epub 2014 May 17. J Hosp Infect. 2014. PMID: 24996516 Review.
Cited by
-
Host and Clostridioides difficile-Response Modulated by Micronutrients and Glutamine: An Overview.Front Nutr. 2022 Jun 20;9:849301. doi: 10.3389/fnut.2022.849301. eCollection 2022. Front Nutr. 2022. PMID: 35795588 Free PMC article. Review.
-
PhosphoLipidome Alteration Induced by Clostridioides difficile Toxin B in Enteric Glial Cells.Cells. 2024 Jun 26;13(13):1103. doi: 10.3390/cells13131103. Cells. 2024. PMID: 38994956 Free PMC article.
-
Knowledge, perceptions, and beliefs about urinary tract infections in persons with neurogenic bladder and impacts on interventions to promote person-centered care.Spinal Cord. 2024 May;62(5):221-227. doi: 10.1038/s41393-024-00972-z. Epub 2024 Mar 7. Spinal Cord. 2024. PMID: 38454065 Free PMC article.
-
Influence of Binary Toxin Gene Detection and Decreased Susceptibility to Antibiotics among Clostridioides difficile Strains on Disease Severity: a Single-Center Study.Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0048922. doi: 10.1128/aac.00489-22. Epub 2022 Jul 21. Antimicrob Agents Chemother. 2022. PMID: 35861541 Free PMC article.
-
A new score to predict Clostridioides difficile infection in medical patients: a sub-analysis of the FADOI-PRACTICE study.Intern Emerg Med. 2023 Oct;18(7):2003-2009. doi: 10.1007/s11739-023-03395-5. Epub 2023 Aug 26. Intern Emerg Med. 2023. PMID: 37633862
References
-
- Centers for Disease Control and Prevention Antibiotic resistance threats in the United States, 2013. https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Published April 23, 2013. Accessed November 7, 2019.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous